EQT Fund Management’s Evommune EVMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.7M Hold
5,288,313
– – 4.61% 5
2026
Q2
$70.3M Buy
5,288,313
+358,680
+7% +$8.33M 8.15% 4
2026
Q1
$113M Hold
4,929,633
– – 11.1% 3
2025
Q4
$84.4M Buy
+4,929,633
New +$92.6M 7.59% 4

Other funds holding EVMN

EQT Fund Management's EVMN Position: Q3 2026 in Review

EQT Fund Management held its Evommune (EVMN) position steady in Q3 2026 at 5,288,313 shares worth $43.7M. The position accounts for 4.61% of the portfolio, ranked #5.

EQT Fund Management first reported a position in EVMN in Q4 2025 and has held it in 4 quarters since. The position peaked at $113M in Q1 2026. 104 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • EQT Fund Management held 5,288,313 shares of Evommune worth $43.7M as of Q3 2026.
  • EQT Fund Management left its Evommune share count unchanged in Q3 2026.
  • Evommune made up 4.61% of EQT Fund Management's portfolio in Q3 2026, its #5 holding.
  • EQT Fund Management first reported a position in Evommune in Q4 2025 and has held it in 4 quarters since.
  • EQT Fund Management's Evommune position peaked at $113M in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Evommune as of Q3 2026.

Based on EQT Fund Management's 13F filing for Q3 2026, filed 12 Nov 2026.